Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors

摘要

The present disclosure provides methods of treating a patient having a respiratory disorder, identifying a subject with an increased risk of developing a respiratory disorder, and detecting a human arachidonate 15-lipoxygenase (ALOX15) variant nucleic acid molecule and variant polypeptide to provide.